Your online Gateway to WellSpring Pharmaceutical Canada Corp in 2011
400 Iroquois Shore Road,
Oakville Ontario L6H 1M5 Canada
1-866-337-4500
Fax: 905-337-7239
http://www.wellspringcmo.com
About WellSpring Pharmaceutical Canada Corp
With WellSpring Pharmaceutical Contract Services our ability is your solution for manufacturing and packaging of virtually all finished non-sterile, solid and semi-solid dose products. We also provide clinical manufacturing, over-encapsulation, labeling, packaging, storage, distribution and returned goods management to support our clients’ most complex clinical trial requirements.
Our capabilities include blending, granulation, tablet compression, encapsulation, film coating, and topicals and liquids processing. Extensive packaging capabilities enable tablets or capsules to be bottled or blister-sealed and topical products can be supplied in jars and tubes. Our facility and quality systems have been successfully inspected by FDA and Health Canada.
Please visit WellSpring Pharmaceutical for manufacturing, packaging, analytical and distribution services for clinical and commercial supplies. Contact us to arrange a convenient time to discuss how we can provide contract services supply chain solutions for virtually all finished non-sterile, liquids, semi-solids and solid dosage form products. WellSpring’s outstanding customer service and flexibility will ensure your supply chain needs are met.
For more information:
info@wellspringcmo.com
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.